Greg Wolf to Feasibility Studies
This is a "connection" page, showing publications Greg Wolf has written about Feasibility Studies.
Connection Strength
0.024
-
Malhotra B, Moon J, Kucuk O, Clark JI, Urba SG, Wolf GT, Worden FP. Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329. Head Neck. 2014 Dec; 36(12):1712-7.
Score: 0.024